Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

Nature Medicine

Volumn 7, Issue 3, 2001, Pages 297-303

  Wolfers, Joseph ^a   Lozier, Anne ^a   Raposo, Graça ^b   Regnault, Armelle ^c   Théry, Clotilde ^c   Masurier, Carole ^a   Flament, Caroline ^a   Pouzieux, Stéphanie ^a   Faure, Florence ^c   Tursz, Thomas ^a   Angevin, Eric ^a   Amigorena, Sebastian ^c   Zitvogel, Laurence ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT CURIE   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR REJECTION ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL TRANSPORT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IMMUNOREACTIVITY; IN VITRO STUDY; MEMBRANE VESICLE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, NEOPLASM; DENDRITIC CELLS; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICROSCOPY, IMMUNOELECTRON; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 20244373139     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/85438     Document Type: Article

References (41)

1. Human tumor antigens recognized by T lymphocytes
2. A new era for cancer immunotherapy based on the genes that encode cancer antigens
3. The makings of a tumor rejection antigen
4. Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochtonous host
5. Antigenic properties of chemically induced tumors
6. Cancer immunology, the search for specificity
7. The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for CTL but also for tumor rejection
8. Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross-protected
9. Natural cytotoxic T cell response in a spontaneously re- gressing human melanoma targets a neoantigen resulting from a somatic point mutation
10. Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigens
11. B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by the majority of HLA-A2-restricted CD8+ CTL
12. Dendritic cells acquire antigen from apoptotic cells and induce class l-restricted CTLs
13. DC acquire the MAGE3 human tumor antigen from apoptotic cells and induce a class l-restricted T cell response
14. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo
15. Heat shock proteins transfer peptides during antigen processing and CTL priming
16. Immunotherapy of tumors with autologous tumor derived heat shock protein preparations
17. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in viva
18. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA
19. B lymphocytes secrete antigen-presenting vesicles
20. Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes
21. Molecular characterization of dendritic cell-derived exosomes: Selective accumulation of the heat shock protein hsc73
22. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B lymphocytes
23. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α
24. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines
25. Diversity of the cytotoxic melanoma-specific immune response: Some CTL clones recognize autologous fresh tumor cells and not tumor cell lines
26. Human renal cell carcinoma xenografts in SCID mice: Tumorigenicity correlates with a poor clinical prognosis
27. Dendritic cells directly trigger NK cell functions: A cross-talk relevant in innate antitumor immune responses in vivo
28. BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line
29. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo
30. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation
31. In Situ demonstration of renal-cell-carcinoma-specific T-cell clones
32. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity
33. Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface
34. Recycling MHC class l molecules and endosomal peptide loading
35. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas
36. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor
37. Exosome formation during maturation of mammalian and avian reticulocytes: Evidence that exosome release is a major route for externalization of obsolete membrane proteins
38. Exosomes released during reticulocyte maturation bind to fibronectin via α4β1
39. Immunotherapy with CTLs restricted by nonself MHC
40. The alphavbeta5 integrin recruits the Crk/Dock180 molecular complex for phagocytosis of apoptotic cells
41. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells